McDermott Will & Emery represented SubjectWell in the transaction. SubjectWell, a Texas-based provider of the most accurate, diverse, predictable, and patient-centric patient recruitment platform and portfolio...
SubjectWell’s Acquisition of Trials24
VR Equitypartner’s Acquisition of a Minority Stake in Accso
McDermott Will & Emery has advised VR Equitypartner on the deal. VR Equitypartner GmbH announced the acquisition of a significant minority stake in Accso – Accelerated...
Lifespin GmbH’s Partnership with Acibadem University and Acibadem Healthcare Group
McDermott Will & Emery represented lifespin GmbH on the transaction. German lifespin GmbH, a pioneer in health status detection software, announced it has formed a partnership...
The Sterling Group and Capitol Meridian Partners’ Acquisition of Primeflight Aviation Services
McDermott Will & Emery is serving as legal counsel to Capitol Meridian Partners and The Sterling Group, while Latham & Watkins is serving as legal counsel...
H.I.G. Capital’s Acquisition of Celerion
Homburger and McDermott Will & Emery advised H.I.G. Capital on the deal, while Winston & Strawn advised Celerion. H.I.G. Capital, a leading global investment firm with...
Myonex’s Acquisition of Hubertus’ Clinical Trial Business Unit
McDermott Will & Emery and Greenfort advised Myonex on the deal. Myonex Inc, a leading global provider of clinical trial supply solutions, executed its acquisition of...
Vivitide’s Business Combination With Biosynth Carbosynth
McDermott Will & Emery represented Ampersand Capital Partners in the transaction. Ampersand Capital Partners, a healthcare-focused private equity fund, and KKR, a leading global investment firm, finalized...